Nephrology Medical News about Cinacalcet

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Simultaneous Control of PTH and CaxP Is Sustained over Three Years of Treatment with Cinacalcet HCl
Clinical Journal of the American Society of Nephrology, 09/10/09

Sprague SM et al. – Cinacalcet, by simultaneously lowering PTH, calcium, phosphorus, and calcium–phosphorus levels, may maintain PTH and mineral balance in these individuals. However, as with traditional therapies, long–term data are limited. Cinacalcet effectively maintained PTH, Ca and P reductions in dialysis subjects for up to 180 wk.

<< Previous
Regulation of the mitochondrial permeability transition in kidney...

Next >>
Considering health insurance: how do dialysis initiates with...

Middle-term use of Cinacalcet in paediatric dialysis patients
Pediatric Nephrology, 10/28/09 Relevance Score: 87%

Cinacalcet Treatment of Primary Hyperparathyroidism: Biochemical and Bone Densitometric Outcomes in a Five-Year Study
Journal of Clinical Endocrinology and Metabolism, 10/21/09 Relevance Score: 83%

Restoration of reversed whole PTH/intact PTH ratio and reduction in parathyroid gland vascularity during cinacalcet therapy for severe hyperparathyroidism in a uraemic patient
Nephrology Dialysis Transplantation, 11/09/09 Relevance Score: 80%